FAQs

Show All
Where is LAVA Therapeutics’ corporate headquarters?
LAVA Therapeutics is headquartered at Yalelaan 60 3584 CM Utrecht, the Netherlands.
When was the company founded?
LAVA Therapeutics was founded and commenced operations in 2016.
When did LAVA Therapeutics go public?
LAVA Therapeutics’ initial public offering (IPO) occurred on March 24, 2021.
When is LAVA Therapeutics’ fiscal year-end?
LAVA Therapeutics’ fiscal year ends on December 31st.
How is LAVA Therapeutics’ stock traded?
LAVA Therapeutics is traded on the NASDAQ Global Market under the ticker symbol LVTX, and its CUSIP number is N51517 105.
Who is LAVA Therapeutics’ transfer agent?
Computershare Trust Company, N.A.
Who are LAVA Therapeutics’ independent auditors?
PricewaterhouseCoopers Accountants N.V.
Boschdijktunnel 10
611 AG Eindhoven
The Netherlands
Who is LAVA Therapeutics’ legal counsel?
Cooley LLP 
One Freedom Square
Reston, Virginia 20190
(703) 456-8000

NautaDutilh
Beethovenstraat 400
1082 PR Amsterdam
The Netherlands
+31 20 717 10 0
 
Where can I get the latest corporate news releases and financial reports?
LAVA Therapeutics’ press release archives can be viewed here.
How can I view documents LAVA Therapeutics has filed with the Securities & Exchange Commission (SEC)?
LAVA Therapeutics’ SEC filings can be viewed here.
Whom should I contact if I have further questions?
You can submit queries to LAVA Therapeutics’ investor relations department by contacting ir@LAVAtherapeutics.com.